6 ML clindamycin 150 MG/ML Injection [Cleocin]
clindamycin
RxCUI: 1737582
What the CMS Formulary Data Shows for 6 ML clindamycin 150 MG/ML Injection [Cleocin]
Per the CMS 2026 Part D formulary file, 6 ML clindamycin 150 MG/ML Injection [Cleocin] (RxNorm concept RXCUI 1737582, generic name clindamycin) appears on 2 distinct formulary files spanning 9 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to 6 ML clindamycin 150 MG/ML Injection [Cleocin] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 455 Part D beneficiaries filled 6 ML clindamycin 150 MG/ML Injection [Cleocin] in 2023, with total plan-and-beneficiary spending of $166,113 and an average per-beneficiary annual cost of $365.08. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 6 ML clindamycin 150 MG/ML Injection [Cleocin] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 9
- Coverage rate
- 0.2%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 455
- Total spending
- $166,113
- Avg per beneficiary
- $365.08
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 6 ML clindamycin 150 MG/ML Injection [Cleocin]
9 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | GATEWAY HEALTH PLAN, INC. | T1 | No | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | GATEWAY HEALTH PLAN, INC. | T1 | No | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | HIGHMARK HEALTH OPTIONS WEST VIRGINIA INC. | T1 | No | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | HIGHMARK BCBSD, INC. | T1 | No | $0 | DE |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | GATEWAY HEALTH PLAN, INC. | T1 | No | $13.10 | PA |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | GATEWAY HEALTH PLAN, INC. | T1 | No | $17.60 | PA |
| Highmark Health Options Duals Select (HMO D-SNP) | HIGHMARK BCBSD, INC. | T1 | No | $31.20 | DE |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is 6 ML clindamycin 150 MG/ML Injection [Cleocin] covered by Medicare Part D?
Yes, 6 ML clindamycin 150 MG/ML Injection [Cleocin] is covered by 9 Medicare Part D plans (0.2% of all Part D formularies).
What tier is 6 ML clindamycin 150 MG/ML Injection [Cleocin] on Medicare Part D plans?
6 ML clindamycin 150 MG/ML Injection [Cleocin] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does 6 ML clindamycin 150 MG/ML Injection [Cleocin] require prior authorization?
0% of Part D formularies require prior authorization for 6 ML clindamycin 150 MG/ML Injection [Cleocin]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on 6 ML clindamycin 150 MG/ML Injection [Cleocin]?
In 2023, total Medicare Part D spending on 6 ML clindamycin 150 MG/ML Injection [Cleocin] was $166,113, covering 455 beneficiaries. The average spend per beneficiary was $365.08.
Read our methodology - how this data is sourced, computed, and verified.